Improving Early Detection of Pathological Complete Response in Breast Cancer through Attention-Based Convolutional Neural Networks in Digital Pathology - Scorecard - MDSpire

Improving Early Detection of Pathological Complete Response in Breast Cancer through Attention-Based Convolutional Neural Networks in Digital Pathology

  • By

  • Maria Colomba Comes

  • Andrea Lupo

  • Arianna Bozzi

  • Annarita Fanizzi

  • Angelo Cirillo

  • Giorgio De Nunzio

  • Maria Irene Pastena

  • Alessandro Rizzo

  • Deniz Can Guven

  • Elsa Vitale

  • Francesco Alfredo Zito

  • Samantha Bove

  • Raffaella Massafra

  • January 1, 2026

  • 0 min

Share

Clinical Scorecard: Improving Early Detection of Pathological Complete Response in Breast Cancer through Attention-Based Convolutional Neural Networks in Digital Pathology

At a Glance

CategoryDetail
ConditionBreast Cancer
Key MechanismsNeoadjuvant chemotherapy (NAC) and digital pathology with convolutional neural networks (CNNs)
Target PopulationPatients with unilateral invasive breast carcinoma undergoing NAC
Care SettingOncology clinics and research institutions

Key Highlights

  • NAC is crucial for shrinking tumors prior to surgery, improving outcomes.
  • Pathological complete response (pCR) is a key prognostic indicator.
  • Digital pathology enhances the prediction of pCR through high-resolution imaging.
  • AI integration, particularly CNNs, improves analysis of biopsy images.
  • Early prediction of pCR can optimize treatment strategies and reduce toxicity.

Guideline-Based Recommendations

Diagnosis

  • Utilize digital pathology and advanced imaging techniques for pCR prediction.

Management

  • Adapt treatment strategies based on early pCR predictions.

Monitoring & Follow-up

  • Regular assessment of tumor response through imaging and biopsy analysis.

Risks

  • Potential for unnecessary toxicity if pCR is not accurately predicted.

Patient & Prescribing Data

Breast cancer patients treated with NAC, including those with HER2-positive and triple-negative subtypes.

Digital pathology and AI can provide cost-effective and precise predictions of treatment outcomes.

Clinical Best Practices

  • Incorporate digital pathology into routine clinical workflows for breast cancer management.
  • Use AI-enhanced models to improve the accuracy of pCR predictions.

References

Original Source(s)

Related Content